Deng Jie, Wulff-Burchfield Elizabeth M, Murphy Barbara A
School of Nursing, University of Pennsylvania, Philadelphia, PA.
University of Kansas Medical Center, Kansas City, KS.
J Natl Cancer Inst Monogr. 2019 Aug 1;2019(53). doi: 10.1093/jncimonographs/lgz005.
Head and neck cancer and its treatment result in soft tissue damage secondary to lymphedema and fibrosis. Lymphedema is the result of pathological accumulation of interstitial fluid in tissues. It is caused by the inability of the lymphatic system to transport lymph fluid from the tissues to the central circulatory system and is manifested clinically by tissue swelling. Fibrosis is defined as an overaccumulation of fibrotic tissues within the skin and soft tissues after a single or repetitive injury and is characterized by hardening of the soft tissues with associated loss of elasticity. Lymphedema and fibrosis are common yet overlooked late effects of head and neck cancer and its therapy. They may result in profound long-term symptom burden, loss of critical functions, and altered quality of life. The following review will discuss the current pathobiology, clinical manifestations, and future directions for research related to lymphedema and fibrosis.
头颈癌及其治疗会导致继发于淋巴水肿和纤维化的软组织损伤。淋巴水肿是组织中间质液病理性积聚的结果。它是由淋巴系统无法将淋巴液从组织输送到中央循环系统引起的,临床症状表现为组织肿胀。纤维化被定义为单次或重复性损伤后皮肤和软组织内纤维组织过度积聚,其特征是软组织硬化并伴有弹性丧失。淋巴水肿和纤维化是头颈癌及其治疗常见但被忽视的晚期效应。它们可能导致严重的长期症状负担、关键功能丧失以及生活质量改变。以下综述将讨论与淋巴水肿和纤维化相关的当前病理生物学、临床表现及未来研究方向。